Siddhartha Ganguly, University of Kansas Cancer Center, Kansas City, US, discusses how treatment varies for patients with multiple myeloma depending on socioeconomic and racial/ethnic factors. This talk during ASCO 2019 touched on three main areas; disparities in rural America, global disparities, and racial disparities. Siddhartha Ganguly highlighted that racial factors, as well as rural postcodes, led to a lower access and utilization of novel agents and stem cell transplant and there is a need to improve access and delivery. He concluded that since patient outcomes and responses are the same, when these factors are removed, it is access that is the issue. Siddhartha Ganguly also thanked ASCO for raising this important topic.
The European School of Haematology (ESH) is a not for profit institution for the dissemination of information and lifelong learning founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in haematology and related disciplines at the European level. ESH Conferences present state-of-the-art science and insight into new developments in the fields of basic, clinical and therapeutic research in Haematology